Stock ONWD ONWARD MEDICAL N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Onward Medical N.V.

Equities

ONWD

NL0015000HT4

Market Closed - Euronext Bruxelles
Other stock markets
 11:35:21 2024-04-26 am EDT 		5-day change 1st Jan Change
4.69 EUR +1.08% Intraday chart for Onward Medical N.V. -7.68% +51.29%
Apr. 25 Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 02 Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy MT

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company has insufficient levels of profitability.
  • One of the major weak points of the company is its financial situation.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ONWARD MEDICAL N.V. Stock Onward Medical N.V.
+51.29% 173M -
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.17% 12.38B
B-
PENUMBRA, INC. Stock Penumbra, Inc.
-18.74% 7.92B
C+
MASIMO CORPORATION Stock Masimo Corporation
+16.15% 7.2B
C-
GETINGE AB Stock Getinge AB
+4.81% 5.84B
B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+5.99% 5.07B
D+
APT MEDICAL INC. Stock APT Medical Inc.
+27.07% 4.53B -
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.67% 3.88B
B-
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-40.82% 2.23B
C
SKAN GROUP AG Stock SKAN Group AG
+1.49% 2.02B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ONWD Stock
  4. Ratings Onward Medical N.V.